Medicine · Neuroscience
| ISSN | 22143599, 22143602 |
|---|---|
| Country | Netherlands |
| Publisher | IOS Press BV |
| Subject Areas | Medicine · Neuroscience |
| Publication Type | Journals |
| Active Years | 2014-2021 |
| Website | Visit journal |
| JIF 2022–2023 | 3.200 |
The Journal of Neuromuscular Diseases aims to facilitate progress in understanding the molecular geneticscorrelates pathogenesis pharmacology diagnosis and treatment of acquired and genetic neuromuscular diseases including muscular dystrophy myasthenia gravis spinal muscular atrophy neuropathies myopathies myotonias and myositis. The journal publishes research reports reviews short communications letterstotheeditor and will consider research that has negative findings. The journal is dedicated to providing an open forum for original research in basic science translational and clinical research that will improve our fundamental understanding and lead to effective treatments of neuromuscular diseases.
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2022 | 2.902 | 3.284 | 3.536 |
| 2021 | 4.438 | 4.586 | 4.420 |
| 2020 | 4.515 | 4.168 | 4.011 |
| 2019 | 2.932 | 2.977 | 2.957 |
| 2018 | 2.544 | 2.610 | 2.513 |
| 2017 | 1.850 | 1.783 | 1.783 |
| 2016 | 1.104 | 1.104 | 1.104 |
| 2015 | 1.700 | 1.700 | 1.700 |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 0.949 |
| 2022 | 1.002 |
| 2021 | 1.054 |
| 2020 | 1.366 |
| 2019 | 1.091 |
| 2018 | 0.992 |
| 2017 | 0.752 |
| 2016 | 0.684 |
| 2015 | 0.630 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 39.000 |
| 2022 | 34.000 |
| 2021 | 29.000 |
https://mstracker.com/submit1_dev.php?jc2=jnmd&SubmitType=N